The Definitive Peptide Research Reference Guide — Compound Review

Home Compounds BPC-157 TB-500 CJC-1295 Ipamorelin GLP-1 GHK-Cu Epithalon NAD+ Comparisons BPC-157 vs TB-500 Sermorelin vs Ipamorelin Semaglutide vs Tirzepatide Guides GHK-Cu Guide GHRH Analogues Ipamorelin Guide Semaglutide Dosage BPC-157 Dosage Research Guides Joint Pain Weight Loss Longevity Shop Purgo Labs

Tirzepatide FDA Approval: Mounjaro, Zepbound & All Approved Indications (2026)

Tirzepatide FDA approval timeline: Mounjaro (type 2 diabetes, May 2022), Zepbound (obesity, November 2023; obstructive sleep apnea, December 2024). Approved doses, plus pending heart-failure (HFpEF) and cardiovascular indications.